BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4520847)

  • 1. Gas chromatographic-mass spectrometric identification of N:N-dimethyltryptamine in urine samples from drug-free chronic schizophrenic patients and its quantitation by the technique of single (selective) ion monitoring.
    Narasimhachari N; Himwich HE
    Biochem Biophys Res Commun; 1973 Dec; 55(4):1064-71. PubMed ID: 4520847
    [No Abstract]   [Full Text] [Related]  

  • 2. Gas chromatographic-mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug-free chronic schizophrenic patients.
    Narasimhachari N; Baumann P; Pak HS; Carpenter WT; Zocchi AF; Hokanson L; Fujimori M; Himwich HE
    Biol Psychiatry; 1974 Jun; 8(3):293-305. PubMed ID: 4527813
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of drug-free schizophrenics and controls.
    Narasimhachari N; Avalos J; Fujimori M; Himwich HE
    Biol Psychiatry; 1973 Dec; 5(3):311-8. PubMed ID: 4513564
    [No Abstract]   [Full Text] [Related]  

  • 4. Occurrence of bufotenin (5-hydroxy-N,N-dimethyltryptamine) in urine of schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Life Sci; 1967 Aug; 6(16):1697-706. PubMed ID: 6057885
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylated psychotogens in the urine of psychiatric patients.
    Kanabus P; Krysa G; Matsumoto H; Stencka K
    Act Nerv Super (Praha); 1973 May; 15(2):124. PubMed ID: 4518608
    [No Abstract]   [Full Text] [Related]  

  • 6. Gas chromatographic-mass spectroscopic characterisation of the psychotomimetic indolealkylamines and their in vivo metabolites.
    Sitaram BR; Lockett L; McLeish M; Hayasaka Y; Blackman GL; McLeod WR
    J Chromatogr; 1987 Nov; 422():13-23. PubMed ID: 3481368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [N,N-dimethyltryptamine and bufotenin in the urine of patients with chronic and acute schizophrenic psychoses].
    Rosengarten H; Szemis A; Piotrowski A; Romaszewska K; Matsumoto H; Stencka K; Jus A
    Psychiatr Pol; 1970; 4(5):519-21. PubMed ID: 5483205
    [No Abstract]   [Full Text] [Related]  

  • 8. A gas chromatographic procedure for determining N, N-dimethyltryptamine and N-monomethyltryptamine in urine using a nitrogen detector.
    Oon MC; Rodnight R
    Biochem Med; 1977 Dec; 18(3):410-9. PubMed ID: 271509
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of psychotomimetic N,N-dimethylated indoleamines in the urine of four schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Br J Psychiatry; 1970 Oct; 117(539):421-30. PubMed ID: 5312352
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological heterogeneity in schizophrenic patients.
    Buchsbaum MS; Davis GC
    Am J Psychiatry; 1979 Dec; 136(12):1618. PubMed ID: 292318
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC/ESI-MS-MS.
    Forsström T; Tuominen J; Karkkäinen J
    Scand J Clin Lab Invest; 2001; 61(7):547-56. PubMed ID: 11763413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gas chromatographic-mass spectrometric isotope dilution determination of N,N-dimethyltryptamine concentrations in normals and psychiatric patients.
    Wyatt RJ; Mandel LR; Ahn HS; Walker RW; Vanden Heuvel WJ
    Psychopharmacologia; 1973 Jul; 31(3):265-70. PubMed ID: 4517484
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary excretion of n,n-dimethylated tryptamines in chronic schizophrenia. A review of the present status of the hypothesis.
    Huszka L; Zabek DH; Doust JW
    Can Psychiatr Assoc J; 1976 Dec; 21(8):541-6. PubMed ID: 1071579
    [No Abstract]   [Full Text] [Related]  

  • 14. The excretion of dimethyltryptamine in psychiatric patients.
    Murray RM; Oon MC
    Proc R Soc Med; 1976 Nov; 69(11):831-2. PubMed ID: 1070023
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects.
    Oon MC; Murray RM; Rodnight R; Murphy MP; Birley JL
    Psychopharmacology (Berl); 1977 Oct; 54(2):171-5. PubMed ID: 22091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gas chromatographic-mass spectrometric isotope dilution assay for N,N-dimethyltryptamine in human plasma.
    Walker RW; Ahn HS; Albers-Schönberg G; Mandel LR; Vandenheuvel WJ
    Biochem Med; 1973 Aug; 8(1):105-13. PubMed ID: 4582927
    [No Abstract]   [Full Text] [Related]  

  • 17. A longitudinal study of urinary excretion of N,N,-dimethyltryptamine in psychotic patients.
    Checkley SA; Murray RM; Oon MC; Rodnight R; Birley JL
    Br J Psychiatry; 1980 Sep; 137():236-9. PubMed ID: 6777009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of dimethyltryptamine in liver disease.
    Checkley SA; Oon MC; Rodnight R; Murphy MP; Williams RS; Birley JL
    Am J Psychiatry; 1979 Apr; 136(4A):439-41. PubMed ID: 284722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary studies of schizophrenics and controls.
    Narasimhachari N; Heller B; Spaide J; Haskovec L; Fujimori M; Tabushi K; Himwich HE
    Biol Psychiatry; 1971; 3(1):9-20. PubMed ID: 4398666
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative studies of indolethylamine-N-methyl transferase activity by thin-layer chromatographic, gas chromatographic, gas chromatographic-mass spectrometric and radiometric methods.
    Narasimhachari N; Lin RL
    Biochem Med; 1974 Oct; 11(2):171-9. PubMed ID: 4533240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.